Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT06263868
Eligibility Criteria:
Inclusion Criteria:
Precocious puberty group (PP) :
* Suspected precocious puberty (girl aged \< 8 years or boy aged \< 9 years when the first signs of development\* appear)
* Suspected precocious puberty (girl aged \< 8 years or boy aged \< 9 years when the first signs of development\* appear)
Advanced puberty group (AP) :
* Suspected advanced puberty (girl aged ≥ 8 and \< 10 years or boy aged ≥ 9 and \< 11 years when the first signs of development\* appear)
* First consultation with the investigator (pediatric endocrinologist).
Control group :
* Boy or girl without signs of pubertal development (Tanner 1);
* Matched to the PP group on sex and age (+/- 1 year);
* Consultation with the same investigator over the same period (same quarter) as a patient in the PP group
Exclusion Criteria:
All groups
* Consultation with the same investigator over the same period (same quarter) as a patient in the PP group
* Family not speaking French, language barrier.
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
11 Years
Study:
NCT06263868
Study Brief:
Protocol Section:
NCT06263868